Chemomab Therapeutics Ltd.
Stock Forecast, Prediction & Price Target

Chemomab Therapeutics Ltd. Financial Estimates

Chemomab Therapeutics Ltd. Revenue Estimates

Chemomab Therapeutics Ltd. EBITDA Estimates

Chemomab Therapeutics Ltd. Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $24.4M
Low: $24.4M
High: $24.4M
avg. 0%
Avg: $36.2M
Low: $36.2M
High: $36.2M
avg. 48.36%
Avg: $0
Low: $0
High: $0
avg. -100%
Net Income
 
% change YoY
$-12.55M
 
N/A
$-27.64M
 
-120.19%
$-24.22M
 
12.38%
Avg: $-23.14M
Low: $-11.98M
High: $-469.99K
avg. 4.45%
Avg: $-27.20M
Low: $-11.04M
High: $-587.49K
avg. -17.55%
Avg: $-4.19M
Low: $-4.19M
High: $-4.19M
avg. 84.59%
Avg: $-4.50M
Low: $-4.50M
High: $-4.50M
avg. -7.47%
EBITDA
 
% change YoY
$-12.36M
 
N/A
$-28.47M
 
-130.24%
$-25.39M
 
10.82%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$1.21
 
N/A
-$2.43
 
-100.82%
-$2.06
 
15.22%
Avg: -$0.37
Low: -$1.02
High: -$0.04
avg. 82.03%
Avg: -$0.35
Low: -$0.94
High: -$0.05
avg. 6.30%
Avg: -$0.36
Low: -$0.36
High: -$0.36
avg. -2.88%
Avg: -$0.38
Low: -$0.38
High: -$0.38
avg. -7.47%
Operating Expenses
 
% change YoY
$12.36M
 
N/A
$28.53M
 
130.71%
$25.45M
 
-10.77%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Chemomab Therapeutics Ltd. stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 16.00% in 2025-2028.

We have gathered data from 2 analysts. Their low estimate is -11.98M, average is -23.14M and high is -469.99K.

What is Chemomab Therapeutics Ltd. stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 12.09% in 2025-2028.

We have gathered data from 3 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.

What is Chemomab Therapeutics Ltd. stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 19.49% in 2025-2028.

We have gathered data from 2 analysts. Their low earnings per share estimate is -$1.02, average is -$0.37 and high is $-0.04.